Navigation Links
Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti-Infection Treatments
Date:8/6/2009

UMEA, Sweden, August 6 /PRNewswire/ -- Omnio Healer AB, a pioneer company developing novel therapies for wound healing and anti-infection, today announced that it has entered into a partnership agreement with Eden Biodesign. Under the agreement Eden Biodesign will provide process development and cGMP production services relating to Omnio Healer's lead recombinant protein candidate.

Based on a novel therapeutic concept for wound healing and anti-infection, Omnio Healer is developing drug candidates with potent pro-inflammatory functions. The agreement with Eden Biodesign relates to the expression of proteins using mammalian cell culture for use against several clinical indications, but primarily for studies relating to chronic eardrum wounds.

Omnio Healer selected Eden Biodesign as its preferred manufacturing partner after an extensive due diligence exercise that evaluated numerous contract manufacturing organizations in both Europe and the United States. Eden Biodesign will undertake the development of a robust manufacturing process for the product leading to cGMP production for supplying clinical studies. Omnio Healer has also assessed Eden Biodesign as a potential future commercial manufacturer of the product using Eden's MHRA-inspected state-of-the-art cGMP manufacturing facilities located in Liverpool, UK.

Mats Stromqvist, CEO of Omnio Healer AB, said, "Our protein product has shown very promising preclinical results in wound healing indications. We are now very keen to take the next step and gain access to GMP-material for use in clinical trials. At the same time, we have every confidence that Eden Biodesign will become a valuable partner in this regard, providing both cGMP process development and production."

Eden Biodesign's CEO, Dr. Crawford Brown, commented, "We are extremely happy to have been selected by Omnio Healer to support the development of this important prod
'/>"/>

SOURCE Omnio Healer AB
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Call for Entries - 2008 CURE Extraordinary Healer Award for Oncology Nursing
2. CURE Magazine Announces Winner of 2008 Extraordinary Healer Award
3. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
4. Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software
5. E-Rad Solutions Selects Compressus Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market
6. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
7. GeneSeek Selects the British Midlands as Base for New UK/European Operations
8. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
9. GSA Selects Cascades Technologies, Inc. (CTi) to Support USA.gov
10. ProCure Selects IMPAC as Provider of Oncology Information Systems
11. CIGNA Medical Group Selects Allscripts for Electronic Health Record

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RNewswire/ -- Biotech firm Replikins Ltd., which h...1918 pandemic through the prediction, outbreak, an...ued its latest biochemical analysis of the virus. ...("Swine Flu") virus has dropped from its peak of 3...in the spring of 2009 to resting non-epidemic leve...
(Date:11/25/2009)..., BOCA RATON, Fla., Nov. 25 For ma...o for BodyLogicMD. The nation,s largest and faste...ng exclusively in medically supervised bioidentic...s in its network since November 2008 - from 21 ... physician-owned centers, including one in Puerto ...
(Date:11/25/2009)... 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SV...announced today that it executed,a joint venture (...e,Technology Co., Ltd. (Sinovac Dalian). The JV wi...man-use vaccines. Sinovac will contribute its expe...zing world-class vaccines; the,other party will br...
(Date:11/25/2009)...ewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nas...Pharm.D., president and chief executive officer, w...h Care Conference. , ,Presentation details are as...onference,Date: Tuesday, December 1, 2009,Tim...York Palace Hotel, New York, NY,Webcast: <a hre...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...y way to shape metal has been to "heat and beat." ... involves carving with electron beams or etching w...ed a method to self-assemble metals into complex n...ficient and cheaper catalysts for fuel cells and i...urfaces to make new types of conductors that would...
... partnership venture, NanoInterventions, ...inn. and LONDON, Ontario, June 26 Following,the l...of,NanoInterventions, their cardiovascular joint v...(TM) are pleased to announce their broader,agreeme...t,polyisobutylene-based block copolymers. Nanocopo...
...ientific,Corporation (NYSE: BSX ) will webcast it... the second quarter ended June 30, 2008 on Tuesday...ed by Jim Tobin, President and Chief Executive,Off...hief Financial,Officer., The live webcast and arc...tp://www.bostonscientific.com in the Investor Rel...
Other Biology Technology:In 'novel playground,' metals are formed into porous nanostructures 2In 'novel playground,' metals are formed into porous nanostructures 3Nanocopoeia Licenses New Polymer-Based Biomaterials Platform From the University of Western Ontario 2Nanocopoeia Licenses New Polymer-Based Biomaterials Platform From the University of Western Ontario 3Nanocopoeia Licenses New Polymer-Based Biomaterials Platform From the University of Western Ontario 4Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results 2
(Date:11/23/2009)...search presents strong evidence that the "synergis... traffic-related pollution and indoor endotoxin ca... other exposure alone. , Environmental health ...llege of Medicine have shown that children exposed...and indoor endotoxin during early life are six tim...
(Date:11/23/2009)...ber 23, 2009 - The time of day matters to forest t...r produced by a research team led by Professor Mal... vice-principal for research and colleagues in the... George campus. , Capitalizing on their previo...he research team examined how poplar trees use the...
(Date:11/23/2009)...Current research suggests that a common oral bacte...ed report by Nichols et al, "Unique Lipids from a ...R2 Ligands Capable of Enhancing Autoimmunity," app...ournal of Pathology . , Multiple sclerosis (MS),...in and spinal cord, affects nearly 1 in 700 people...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Gerton Lab determines the composition of centromeric chromatin 10126 1Gerton Lab determines the composition of centromeric chromatin 10126 2William Fuchs Named to PerfectServe Advisory Board 58395 1William Fuchs Named to PerfectServe Advisory Board 58395 2California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 1California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 2
...rchers have discovered that the antibiotic minocyc...n the brain and central nervous system, problems t... controls the virus elsewhere in the body. , Five...us (SIV), a very close relative of HIV, and treate... less brain inflammation, and less virus in the ce...
...ences taste sensitivity of children and adults, ac...rences and food selection, report a team of resear...ddition to genes, age and culture also contribute ...uence of genetics. , The findings may help to exp...-tasting foods, as well as why taste and food pref...
...ions at particular lifetime points may increase th...e lifetime nonsmokers, a study by epidemiologists ...ound. , Their study was conducted among women who...ate between 1996 and 2001. They found that higher ...polycyclic aromatic hydrocarbons (PAHs), potential...
Other Biology News:Antibiotic might fight HIV-induced neurological problems 2Antibiotic might fight HIV-induced neurological problems 3Children's taste sensitivity and food choices influenced by taste gene 2Children's taste sensitivity and food choices influenced by taste gene 3Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth 2Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth 3
Rat Anti-Mouse TCR, Va 2 Monoclonal Antibody, Unconjugated, Clone B20.1 from CEDARLANE Laboratories Limited
Goat Anti-synphilin-1 (V-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Porcine IFN-gamma ELISpot Kit from R&D Systems
... ELISA Development kit contains the basic componen... to measure natural and recombinant canine Monocyt...pernates and serum.1 Each kit contains sufficient ...6-well plates, provided that the following conditi...
Biology Products: